Literature DB >> 26789901

Cytomegalovirus Retinitis in a Patient Who Received Ruxolitinib.

Joanna von Hofsten1, Marianne Johnsson Forsberg, Madeleine Zetterberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26789901     DOI： 10.1056/NEJMc1413918

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  JAK2 inhibitors for myeloproliferative neoplasms: what is next?

Authors:  Prithviraj Bose; Srdan Verstovsek
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  CMV in Hematopoietic Stem Cell Transplantation.

Authors:  Rafael de la Cámara
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-06-20       Impact factor: 2.576

3.  Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib.

Authors:  Maheen Z Abidi; Javeria Haque; Parvathi Varma; Horatiu Olteanu; Guru Subramanian Guru Murthy; Binod Dhakal; Parameswaran Hari
Journal:  Case Rep Hematol       Date:  2016-10-23

4.  Epstein-Barr virus gastric ulcer associated with ruxolitinib.

Authors:  Yoshiharu Kusano; Yasuhito Terui; Kyoko Ueda; Kiyohiko Hatake
Journal:  Ann Hematol       Date:  2016-07-14       Impact factor: 3.673

5.  Ruxolitinib in myelofibrosis: to be or not to be an immune disruptor.

Authors:  Palma Manduzio
Journal:  Ther Clin Risk Manag       Date:  2017-02-13       Impact factor: 2.423

Review 6.  Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).

Authors:  Georg Maschmeyer; Julien De Greef; Sibylle C Mellinghoff; Annamaria Nosari; Anne Thiebaut-Bertrand; Anne Bergeron; Tomas Franquet; Nicole M A Blijlevens; Johan A Maertens
Journal:  Leukemia       Date:  2019-01-30       Impact factor: 11.528

Review 7.  JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.

Authors:  Ifeanyi Jude Ezeonwumelu; Edurne Garcia-Vidal; Ester Ballana
Journal:  Viruses       Date:  2021-11-27       Impact factor: 5.048

8.  Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic.

Authors:  Fabio Pires de Souza Santos; Renato Sampaio Tavares; Katia Borgia Barbosa Pagnano
Journal:  Hematol Transfus Cell Ther       Date:  2020-06-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.